{
  "meta": {
    "title": "16_Organophosphorus_Poisoning",
    "url": "https://brainandscalpel.vercel.app/16-organophosphorus-poisoning-d38c4556.html",
    "scrapedAt": "2025-11-30T12:28:10.833Z"
  },
  "questions": [
    {
      "text": "Poisoning with which of the following compounds causes mydriasis?",
      "choices": [
        {
          "id": 1,
          "text": "Diazinon"
        },
        {
          "id": 2,
          "text": "Phosdrin"
        },
        {
          "id": 3,
          "text": "Endrin"
        },
        {
          "id": 4,
          "text": "Paraoxon"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Endrin&nbsp;</strong>is an <strong>organochlorine</strong> compound. Poisoning with this compound causes <strong>mydriasis</strong>.&nbsp;There is no specific antidote for organochlorine poisoning.</p>\n<p>Diazinon, phosdrin, and paraoxon are organophosphates and they cause miosis. Organophosphate poisoning is treated with atropine and oximes.</p>\n<p><strong>Classification</strong> of <strong>insecticides</strong>:</p>\n<ul>\n<li>Organophosphorus compounds\n<ul>\n<li>Parathion</li>\n<li><strong>Paraoxon</strong></li>\n<li>Chlorthion</li>\n<li><strong>Diazinon</strong></li>\n<li>Malathion</li>\n<li><strong>Phosdrin</strong></li>\n<li>HETP (hexaethyl tetraphosphate)</li>\n<li>TEPP (tetraethyl pyrophosphate)</li>\n</ul>\n</li>\n<li>Organochlorine compounds\n<ul>\n<li>DDT (dichloro diphenyl trichloroethane)</li>\n<li>Gammahexa-chlorobenzene</li>\n<li><strong>Endrin</strong></li>\n<li>Aldrin</li>\n<li>Endosulfan</li>\n</ul>\n</li>\n<li>Carbamates\n<ul>\n<li>Aldicarb</li>\n<li>Carbaryl</li>\n<li>Carbofuran</li>\n</ul>\n</li>\n<li>Pyrethrin and pyrethroids</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0945",
      "difficulty": "medium"
    },
    {
      "text": "A 36-year-old woman presents to the casualty with diarrhea, miosis, and altered sensorium. Her husband reveals that she has ingested rat poison in an attempt to commit suicide. What is the likely mechanism that is responsible for her clinical presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Inhibition of acetylcholinesterase"
        },
        {
          "id": 2,
          "text": "Carbamylation of carboxylic esterase"
        },
        {
          "id": 3,
          "text": "Oxidation of hemoglobin to methemoglobin"
        },
        {
          "id": 4,
          "text": "Free radical mediated damage"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of <strong>organophosphorus</strong> (OP)<strong> poisoning</strong>. Clinical effects are due to the&nbsp;<strong>inhibition </strong>of<strong> acetylcholinesterase.&nbsp;</strong></p>\n<p>Inhibition of cholinesterase leads to the accumulation of acetylcholine at the nerve synapses and neuromuscular junctions. This results in overstimulation of acetylcholine receptors resulting in a&nbsp;<strong>cholinergic crisis</strong>.</p>\n<p>The <strong>types</strong> of <strong>cholinesterases</strong> are:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Location</strong></td>\n</tr>\n<tr>\n<td>\n<p>Acetylcholinesterase or&nbsp;true or RBC cholinesterase</p>\n</td>\n<td>\n<p>RBC membranes</p>\n<p>Nervous tissue</p>\n<p>Skeletal muscle</p>\n</td>\n</tr>\n<tr>\n<td>Butyrylcholinesterase or plasma cholinesterase or pseudocholinesterase</td>\n<td>\n<p>Serum</p>\n<p>Liver</p>\n<p>Pancreas</p>\n<p>Heart</p>\n<p>Brain</p>\n</td>\n</tr>\n<tr>\n<td>Neuropathy target esterase</td>\n<td>\n<p>Brain</p>\n<p>Kidney</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Acetylcholinesterase or RBC cholinesterase is helpful in the diagnosis of OP poisoning but has no prognostic significance.</p>\n<p>It is hypothesized that inhibition of neuropathy target esterase enzyme may be responsible for organophosphate-induced delayed neuropathy (OPIDN).</p>\n<p>The mechanism of action of the other&nbsp;<strong>agricultural poisons</strong> are:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Compound</strong></td>\n<td><strong>Mechanism of action</strong></td>\n</tr>\n<tr>\n<td>Carbamates</td>\n<td>Carbamylation of carboxylic esterase</td>\n</tr>\n<tr>\n<td>\n<p>Chlorate salts</p>\n<p>(sodium or potassium chlorates)</p>\n</td>\n<td>Oxidation of hemoglobin to methemoglobin</td>\n</tr>\n<tr>\n<td>Paraquat</td>\n<td>Free radical-mediated damage</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0946",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false regarding the clinical syndromes seen in patients with organophosphate poisoning?",
      "choices": [
        {
          "id": 1,
          "text": "CNS symptoms can be seen in acute toxicity"
        },
        {
          "id": 2,
          "text": "Intermediate syndrome can be treated with atropine"
        },
        {
          "id": 3,
          "text": "Chronic toxicity can manifest as symmetrical sensorimotor axonopathy"
        },
        {
          "id": 4,
          "text": "Muscle wasting can be seen in organophosphate-induced delayed neuropathy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Intermediate syndrome</strong> is <strong>unresponsive</strong> to <strong>atropine</strong> and oximes. The syndrome occurs due to prolonged cholinesterase inhibition and muscle necrosis. Maintenance of nutrition, physiotherapy, prevention of bed sores and other routine measures to minimise discomfort along with ventilatory care are management options.</p>\n<p>Four <strong>clinical syndromes</strong> are identified with respect to organophosphate exposure. They include:&nbsp;</p>\n<ol>\n<li><strong>Acute </strong>poisoning -&nbsp;This results in CNS, muscarinic, nicotinic, and somatic motor manifestations.</li>\n<li><strong>Intermediate </strong>syndrome - It is usually observed 1-5 days after OP exposure. It is characterized by paralysis of neck flexors, muscles innervated by cranial nerves, proximal limb muscles, and respiratory muscles.</li>\n<li><strong>Chronic </strong>toxicity -&nbsp;It is seen primarily in agricultural workers with daily exposure. It manifests as symmetrical sensorimotor axonopathy.</li>\n<li><strong>Organophosphate-induced delayed neuropathy</strong> - This is characterized by cognitive dysfunction, extrapyramidal symptoms, and peripheral neuropathy. It can lead to flaccid paralysis and muscle wasting.</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3876",
      "difficulty": "hard"
    },
    {
      "text": "A 25-year-old woman, who was admitted with accidental rodenticide ingestion, was started on atropine. All of the following symptoms would improve in response to therapy except:",
      "choices": [
        {
          "id": 1,
          "text": "Bradycardia"
        },
        {
          "id": 2,
          "text": "Urinary incontinence"
        },
        {
          "id": 3,
          "text": "Muscle cramps"
        },
        {
          "id": 4,
          "text": "Hypotension"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Atropinization in organophosphate (rodenticide) poisoning does not cause regression of nicotinic symptoms like <strong>muscle cramps</strong>. Hence, <strong>oximes</strong> are used for the reversal of <strong>nicotinic</strong> symptoms.</p>\n<p><strong>Atropine&nbsp;</strong>is <strong>effective</strong> against <strong>muscarinic</strong> receptors. It can be used to treat muscarinic symptoms like bradycardia, urinary incontinence, and hypotension.</p><hr><h3>Related Pearl: Muscarinic and Nicotinic Signs and symptoms of Organophosphorus Poisoning</h3><table>\n<tbody>\n<tr>\n<td><strong>Mechanism</strong></td>\n<td><strong>Site affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td rowspan=\"6\"><strong>Muscarinic</strong></td>\n<td>\n<p>Exocrine glands</p>\n</td>\n<td>\n<p>Salivation, lacrimation, perspiration</p>\n</td>\n</tr>\n<tr>\n<td>Eyes</td>\n<td>\n<p>Miosis, blurred vision</p>\n</td>\n</tr>\n<tr>\n<td>GIT</td>\n<td>Abdominal cramps, vomiting, diarrhea</td>\n</tr>\n<tr>\n<td>\n<p>Respiratory tract</p>\n</td>\n<td>Increased secretions, bronchoconstriction</td>\n</tr>\n<tr>\n<td>Bladder</td>\n<td>\n<p>Urinary frequency, incontinence</p>\n</td>\n</tr>\n<tr>\n<td>CVS</td>\n<td>\n<p>Bradycardia, hypotension</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\"><strong>Nicotinic</strong></td>\n<td>\n<p>Skeletal muscles</p>\n</td>\n<td>Muscle fasciculations, Flaccid paralysis</td>\n</tr>\n<tr>\n<td>\n<p>CVS</p>\n<p>(through cholinergic stimulation of sympathetic ganglia)</p>\n</td>\n<td>Tachycardia, Transient hypertension</td>\n</tr>\n<tr>\n<td><strong><span>Muscarinic and nicotinic</span></strong></td>\n<td>CNS</td>\n<td>Dizziness, lethargy, fatigue, headache, mental confusion, depression of respiratory centres, convulsions, coma</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Drugs used in Organophosphorus Poisoning</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n<td>\n<p><strong>Drug used for treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Muscarinic symptoms and CNS effects</p>\n</td>\n<td>Atropine</td>\n</tr>\n<tr>\n<td>\n<p>Nicotinic symptoms</p>\n</td>\n<td>Pralidoxime</td>\n</tr>\n<tr>\n<td>\n<p>Nicotinic &gt;muscarinic and CNS effects</p>\n</td>\n<td>Diacetyl monoxime-specific cholinesterase reactivator</td>\n</tr>\n<tr>\n<td>\n<p>Convulsions</p>\n</td>\n<td>IV diazepam</td>\n</tr>\n<tr>\n<td>\n<p>Pulmonary oedema, bronchospasm</p>\n</td>\n<td>Oxygen, atropine, intubation, positive pressure ventilation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0948",
      "difficulty": "medium"
    },
    {
      "text": "A local informer revealed that decades-old nerve gas cylinders were being smuggled across the border. On arrival of the police at the crime scene, the accused opened fire. One of the bullets accidentally impaled the canister near the police officer. Which of the following symptoms would you expect to see in him?",
      "choices": [
        {
          "id": 1,
          "text": "Hallucinations"
        },
        {
          "id": 2,
          "text": "Miosis"
        },
        {
          "id": 3,
          "text": "Chest pain"
        },
        {
          "id": 4,
          "text": "Joint pain"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Nerve gases </strong>are <strong>organophosphate</strong> compounds in the gaseous form. It manifests with <strong>cholinergic</strong> signs and symptoms, such as&nbsp;<strong>miosis. </strong>It was used&nbsp;in chemical warfare.</p>\n<p>The nerve gases include:</p>\n<ul>\n<li>Soman</li>\n<li>Sarin</li>\n<li>Tabun</li>\n<li>VX</li>\n</ul><hr><h3>Related Pearl: Muscarinic and Nicotinic Signs and symptoms of Organophosphorus Poisoning</h3><table>\n<tbody>\n<tr>\n<td><strong>Mechanism</strong></td>\n<td><strong>Site affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td rowspan=\"6\"><strong>Muscarinic</strong></td>\n<td>\n<p>Exocrine glands</p>\n</td>\n<td>\n<p>Salivation, lacrimation, perspiration</p>\n</td>\n</tr>\n<tr>\n<td>Eyes</td>\n<td>\n<p>Miosis, blurred vision</p>\n</td>\n</tr>\n<tr>\n<td>GIT</td>\n<td>Abdominal cramps, vomiting, diarrhea</td>\n</tr>\n<tr>\n<td>\n<p>Respiratory tract</p>\n</td>\n<td>Increased secretions, bronchoconstriction</td>\n</tr>\n<tr>\n<td>Bladder</td>\n<td>\n<p>Urinary frequency, incontinence</p>\n</td>\n</tr>\n<tr>\n<td>CVS</td>\n<td>\n<p>Bradycardia, hypotension</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\"><strong>Nicotinic</strong></td>\n<td>\n<p>Skeletal muscles</p>\n</td>\n<td>Muscle fasciculations, Flaccid paralysis</td>\n</tr>\n<tr>\n<td>\n<p>CVS</p>\n<p>(through cholinergic stimulation of sympathetic ganglia)</p>\n</td>\n<td>Tachycardia, Transient hypertension</td>\n</tr>\n<tr>\n<td><strong><span>Muscarinic and nicotinic</span></strong></td>\n<td>CNS</td>\n<td>Dizziness, lethargy, fatigue, headache, mental confusion, depression of respiratory centres, convulsions, coma</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0955",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old woman, who is being treated for organophosphate poisoning with atropine, is started on pralidoxime. Which of the following symptoms would regress due to the action of pralidoxime alone?",
      "choices": [
        {
          "id": 1,
          "text": "Miosis"
        },
        {
          "id": 2,
          "text": "Tongue fasciculations"
        },
        {
          "id": 3,
          "text": "Abdominal cramps"
        },
        {
          "id": 4,
          "text": "Hypotension"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Pralidoxime</strong> causes reversal of <strong>tongue fasciculations (nicotinic</strong> symptoms).</p>\n<p>Since <strong>atropine</strong> does not bind to nicotinic receptors, it is <strong>ineffective</strong> in treating <strong>neuromuscular</strong> <strong>dysfunction</strong>. Pralidoxime (2-PAM) and other <strong>oximes</strong>, such as HI-6 and obidoxime, are <strong>cholinesterase-reactivating</strong> agents. Hence, its&nbsp;<strong>coadministration</strong>&nbsp;with atropine is effective in treating both <strong>muscarinic</strong> and <strong>nicotinic</strong> symptoms.</p>\n<p><strong>Pralidoxime&nbsp;reactivates</strong>&nbsp;the&nbsp;<strong>acetylcholinesterase,&nbsp;</strong>which&nbsp;had been deactivated in organophosphate poisoning.&nbsp;Pralidoxime attaches to the anionic site of the enzyme that remains unoccupied. Then it<strong>&nbsp;reacts&nbsp;</strong>with the&nbsp;<strong>phosphorus atom</strong>&nbsp;of the organophosphorous compound which is attached to the esteric site to form a<strong>&nbsp;phospho-oxime complex.&nbsp;</strong>It then dissociates from the enzyme, regenerating the active enzyme.</p>\n<p>Pralidoxime should not be administered without concurrent atropine, in order to prevent worsening of symptoms due to transient oxime-induced acetylcholinesterase inhibition.</p>\n<p>Note: Muscle cramps are nicotinic symptoms. However, abdominal cramps are muscarinic symptoms.</p><hr><h3>Related Pearl: Drugs used in Organophosphorus Poisoning</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n<td>\n<p><strong>Drug used for treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Muscarinic symptoms and CNS effects</p>\n</td>\n<td>Atropine</td>\n</tr>\n<tr>\n<td>\n<p>Nicotinic symptoms</p>\n</td>\n<td>Pralidoxime</td>\n</tr>\n<tr>\n<td>\n<p>Nicotinic &gt;muscarinic and CNS effects</p>\n</td>\n<td>Diacetyl monoxime-specific cholinesterase reactivator</td>\n</tr>\n<tr>\n<td>\n<p>Convulsions</p>\n</td>\n<td>IV diazepam</td>\n</tr>\n<tr>\n<td>\n<p>Pulmonary oedema, bronchospasm</p>\n</td>\n<td>Oxygen, atropine, intubation, positive pressure ventilation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0958",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is true about the intermediate syndrome in organophosphorus poisoning?",
      "choices": [
        {
          "id": 1,
          "text": "Signs of cholinergic excess are seen"
        },
        {
          "id": 2,
          "text": "There is no specific treatment"
        },
        {
          "id": 3,
          "text": "There is weakness of neck extensors"
        },
        {
          "id": 4,
          "text": "Respiratory failure is not a complication"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\">There is&nbsp;<strong>no specific treatment&nbsp;</strong>for the <strong>intermediate syndrome</strong> in organophosphate <strong>(OP) poisoning.</strong></p>\n<p>The intermediate syndrome is seen in 20-50% of acute OP poisoning cases. This syndrome develops <strong>one to several days</strong> after the poisoning, <strong>during</strong> the <strong>recovery</strong> from cholinergic manifestations. In some cases, it can occur when patients have completely recovered from the initial cholinergic crisis.</p>\n<p>Clinical features include <strong>paralysis</strong> of:</p>\n<ul>\n<li><strong>Neck flexor</strong> muscles</li>\n<li>Muscles innervated by the cranial nerves</li>\n<li>Proximal limb muscles</li>\n<li>Respiratory muscles - <strong>respiratory support</strong> may be needed</li>\n</ul>\n<p>Symptoms or signs of <strong>cholinergic excess</strong> are <strong>absent</strong> in this syndrome.</p>\n<p>There is <strong>no specific treatment</strong> for the intermediate syndrome and intervention is exclusively supportive.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0954",
      "difficulty": "medium"
    },
    {
      "text": "A 38-year-old gardener presents with blurred vision, breathlessness, and muscle fasciculations. He gives a history of spraying the solution given in the image a day prior to his symptoms. All of the following are specific indicators of the likely diagnosis except:",
      "choices": [
        {
          "id": 1,
          "text": "Prolonged QTc interval"
        },
        {
          "id": 2,
          "text": "Miosis and muscle fasciculations"
        },
        {
          "id": 3,
          "text": "Resolution of cholinergic symptoms upon atropine administration"
        },
        {
          "id": 4,
          "text": "Fall in RBC cholinesterase levels"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of <strong>malathion</strong> (organophosphate) <strong>poisoning</strong>. In this condition, <strong>prolonged QTc</strong> interval&nbsp;is a&nbsp;<strong>non-specific</strong> finding. However, it&nbsp;correlates with the severity and mortality in severe cases.</p>\n<p>The <strong>reliable indicators</strong> of <strong>OP poisoning</strong> are:</p>\n<ul>\n<li class=\"p1\">Miosis and muscle fasciculations</li>\n<li class=\"p1\">Decrease in RBC cholinesterase levels</li>\n<li class=\"p1\">Absence/ resolution of cholinergic symptoms after an initial dose of atropine</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b8227b1bbe8d44fa8169a7c4fd66e7d3.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0947",
      "difficulty": "medium"
    },
    {
      "text": "You are suspecting organophosphorus poisoning in a farmer who presented with chronic fatigue and urinary incontinence. What would be the most accurate investigation to assess potential toxicity?",
      "choices": [
        {
          "id": 1,
          "text": "Plasma cholinesterase"
        },
        {
          "id": 2,
          "text": "RBC cholinesterase"
        },
        {
          "id": 3,
          "text": "Serum levels of organophosphorus compounds"
        },
        {
          "id": 4,
          "text": "Urinary levels of organophosphorus compound metabolites"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>RBC cholinesterase</strong> enzyme activity is the most <strong>accurate</strong> indicator to assess potential organophosphorus (<strong>OP</strong>) <strong>toxicity</strong>. It is an indicator of synaptic cholinesterase inhibition.</p>\n<p>However,&nbsp;<strong>plasma butyrylcholinesterase</strong> is <strong>easier</strong> to assay and more easily available. Hence, it is more commonly used.</p>\n<p class=\"p1\">Measurement of parent compound in blood and metabolites urine&nbsp;are rarely carried out in a&nbsp;clinical setting.</p>\n<p class=\"p1\">Note: The correlation between cholinesterase activity, clinical symptoms, and atropine dose is inconsistent. Hence, treatment should be guided predominately by clinical symptoms.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0953",
      "difficulty": "medium"
    },
    {
      "text": "In organophosphorus poisoning, clinical manifestations occur when pseudocholinesterase levels fall below:",
      "choices": [
        {
          "id": 1,
          "text": "95% of normal"
        },
        {
          "id": 2,
          "text": "75% of normal"
        },
        {
          "id": 3,
          "text": "60% of normal"
        },
        {
          "id": 4,
          "text": "50% of normal"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In <strong>organophosphorus poisoning,</strong> clinical&nbsp;signs and <strong>symptoms </strong>are observed&nbsp;when <strong>pseudocholinesterase</strong> level falls <strong>below</strong> <strong>50% </strong>of normal.&nbsp;</p>\n<p>Severity of symptoms correlates with&nbsp;pseudocholinesterase levels:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Severity of OP poisoning</strong></td>\n<td><strong>Levels of pseudocholinesterase</strong></td>\n</tr>\n<tr>\n<td>Mild</td>\n<td>40-50%</td>\n</tr>\n<tr>\n<td>Moderate</td>\n<td>10-40%</td>\n</tr>\n<tr>\n<td>Severe</td>\n<td>&lt;10%</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>RBC cholinesterase</strong>&nbsp;enzyme activity is the most&nbsp;<strong>accurate</strong>&nbsp;indicator to assess potential organophosphorus&nbsp;<strong>toxicity</strong>.&nbsp;However,&nbsp;<strong>plasma butyrylcholinesterase</strong>&nbsp;is&nbsp;<strong>easier</strong>&nbsp;to assay and more easily available. Hence, it is more commonly used.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0952",
      "difficulty": "hard"
    },
    {
      "text": "A 7-year-old girl is rushed to the casualty in an unconscious state as she has consumed ant chalks 2 hours ago. On examination, you note the presence of miosis and crackles on chest auscultation. She is hypotensive with PR of 50 bpm, RR of 36 /min, and ECG showing prolonged QTc. You start treating her with atropine sulphate IV. Which of the following will you consider as the therapeutic endpoint?",
      "choices": [
        {
          "id": 1,
          "text": "Pupillary dilation"
        },
        {
          "id": 2,
          "text": "Increase in heart rate"
        },
        {
          "id": 3,
          "text": "Normal ECG"
        },
        {
          "id": 4,
          "text": "Clear chest on auscultation"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of <strong>acute organophosphorus poisoning </strong>which&nbsp;is treated with atropine sulphate.&nbsp;<strong>Clear chest</strong> on <strong>auscultation</strong> indicates clearing of tracheobronchial secretions and cessation of bronchoconstriction. Hence, it is considered as the therapeutic <strong>endpoint</strong> of <strong>atropinization</strong>.&nbsp;</p>\n<p>Tachycardia and mydriasis are&nbsp;not&nbsp;appropriate markers for therapeutic improvement, as they may indicate continued hypoxia, hypovolemia, or sympathetic stimulation.</p>\n<p><strong>Treatment</strong> of organophosphorus poisoning:</p>\n<ul>\n<li>Decontamination</li>\n<li>Airway management</li>\n<li>Stomach wash - water with or without KMnO<sub>4</sub></li>\n<li><strong>Atropine sulphate</strong> at a dose of 2-4 mg IV - highly effective in counteracting the peripheral muscarinic effects and antagonize CNS effects at higher doses</li>\n<li><strong>Oximes</strong> - used early as they have more pronounced action on nicotinic sites</li>\n</ul><hr><h3>Related Pearl: Drugs used in Organophosphorus Poisoning</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n<td>\n<p><strong>Drug used for treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Muscarinic symptoms and CNS effects</p>\n</td>\n<td>Atropine</td>\n</tr>\n<tr>\n<td>\n<p>Nicotinic symptoms</p>\n</td>\n<td>Pralidoxime</td>\n</tr>\n<tr>\n<td>\n<p>Nicotinic &gt;muscarinic and CNS effects</p>\n</td>\n<td>Diacetyl monoxime-specific cholinesterase reactivator</td>\n</tr>\n<tr>\n<td>\n<p>Convulsions</p>\n</td>\n<td>IV diazepam</td>\n</tr>\n<tr>\n<td>\n<p>Pulmonary oedema, bronchospasm</p>\n</td>\n<td>Oxygen, atropine, intubation, positive pressure ventilation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3877",
      "difficulty": "medium"
    },
    {
      "text": "In patients with organophosphate poisoning, which of the following treatment modalities has proven mortality benefits?",
      "choices": [
        {
          "id": 1,
          "text": "Hemodialysis"
        },
        {
          "id": 2,
          "text": "Pralidoxime"
        },
        {
          "id": 3,
          "text": "Oxygen supplementation"
        },
        {
          "id": 4,
          "text": "Urinary alkalinization"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Oxygen supplementation</strong>&nbsp;has proven <strong>clinical </strong>and<strong> mortality benefits</strong> in patients with organophosphate (OP) poisoning who develop<strong> respiratory failure</strong>.</p>\n<p><strong><strong>Pralidoxime</strong></strong>&nbsp;is <strong>not beneficial</strong> in terms of reducing&nbsp;<strong>mortality</strong>, need for ventilator support, and incidence of intermediate syndrome. Despite theoretical and experimental benefits and clinical use worldwide, the current evidence is inadequate. However, until further research has been undertaken, all patients poisoned with organophosphorus agents are recommended to be treated with an oxime.&nbsp;</p>\n<p><strong>Urinary alkalinization, h</strong><strong>emodialysis,</strong> and hemoperfusion have no role in the treatment of OP poisoning.</p>\n<p>Note:&nbsp;Gastric lavage&nbsp;and activated charcoal administration are beneficial only in patients who present within 2 hours following ingestion of OP compounds.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0951",
      "difficulty": "hard"
    },
    {
      "text": "What is the most common cause of mortality in patients with organophosphate poisoning?",
      "choices": [
        {
          "id": 1,
          "text": "Cardiac arrhythmias"
        },
        {
          "id": 2,
          "text": "Renal failure"
        },
        {
          "id": 3,
          "text": "Hypovolemic shock"
        },
        {
          "id": 4,
          "text": "Respiratory failure"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most common cause of <strong>death</strong> in <strong>organophosphate poisoning</strong> is <strong>respiratory failure</strong>. It usually occurs within 24 hours in untreated patients, secondary to paralysis of respiratory muscles.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0961",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements regarding carbamate poisoning is true when compared to organophosphorus poisoning?",
      "choices": [
        {
          "id": 1,
          "text": "It is associated with faster aging of the cholinesterase enzyme"
        },
        {
          "id": 2,
          "text": "It can also lead to the intermediate syndrome"
        },
        {
          "id": 3,
          "text": "Severe CNS toxicity can be seen"
        },
        {
          "id": 4,
          "text": "Pralidoxime is the mainstay in management"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Carbamates</strong> can also lead to the <strong>intermediate syndrome</strong>.</p>\n<p>Option A: Carbamate-cholinesterase bond undergoes rapid, spontaneous hydrolysis which leads to regeneration of the enzyme within a few hours. This is called <strong>reversible carbamylation</strong>. Hence,&nbsp;aging (conversion of the inhibited enzyme into a non-reactivable form) does not occur and the&nbsp;<strong>effect</strong> of carbamate <strong>toxicity</strong> is of a&nbsp;<strong>shorter duration.</strong></p>\n<p>Option C: Carbamates do not effectively penetrate the CNS in adults. Hence, there is&nbsp;less CNS toxicity.</p>\n<p>Option D: <strong>Pralidoxime </strong>is<strong> contraindicated</strong> in carbamate poisoning because it may potentiate the toxicity of carbamates due to its transient oxime-induced cholinesterase inhibition.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0960",
      "difficulty": "hard"
    }
  ]
}